Terazosin Hydrochloride Anhydrous

Product NDC
51079-936
11-digit product format
510790936
Labeler code
51079
Product ID
51079-936_9af1cfd2-0dea-a218-e053-2995a90a4efd
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
terazosin hydrochloride anhydrous
Dosage form
CAPSULE
Route
ORAL
Labeler
Mylan Institutional Inc.
Application
ANDA075140
Marketing category
ANDA
Marketing start
2000-04-01
Marketing end
2021-01-31
Substance
TERAZOSIN HYDROCHLORIDE ANHYDROUS
Active strength
1 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51079-936-01EA - Each51079-9361cdf6248-442b-4fef-b4db-f11284f9826712012-07-24
51079-936-20EA - Each51079-93664de9dda-2319-4aa8-b313-3e497d68ee0512012-07-24